These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28060433)

  • 21. Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.
    Garland A; Weinfurt K; Sugarman J
    Clin Trials; 2021 Dec; 18(6):699-705. PubMed ID: 34766524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical Considerations in Conducting Pragmatic Trials in Oncology.
    Hammer MJ
    Oncol Nurs Forum; 2017 Sep; 44(5):537-539. PubMed ID: 28820523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethics challenges in sharing data from pragmatic clinical trials.
    Morain SR; Bollinger J; Weinfurt K; Sugarman J
    Clin Trials; 2022 Dec; 19(6):681-689. PubMed ID: 36071689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
    Nieuwenhuis JB; Irving E; Oude Rengerink K; Lloyd E; Goetz I; Grobbee DE; Stolk P; Groenwold RH; Zuidgeest MG;
    J Clin Epidemiol; 2016 Sep; 77():95-100. PubMed ID: 27164273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related Research Ethics and Social Value: Antibiotic Resistance Intervention Research and Pragmatic Risks.
    Munthe C; Nijsingh N; de Fine Licht K; Joakim Larsson DG
    Bioethics; 2019 Mar; 33(3):335-342. PubMed ID: 30884548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Argument for Fewer Clinical Trials.
    Borgerson K
    Hastings Cent Rep; 2016 Nov; 46(6):25-35. PubMed ID: 27711966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
    Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
    J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making trials matter: pragmatic and explanatory trials and the problem of applicability.
    Treweek S; Zwarenstein M
    Trials; 2009 Jun; 10():37. PubMed ID: 19493350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia.
    Alphs L; Schooler N; Lauriello J
    Schizophr Res; 2014 Jul; 156(2-3):228-32. PubMed ID: 24842538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.
    Anderson ML; Califf RM; Sugarman J;
    Clin Trials; 2015 Jun; 12(3):276-86. PubMed ID: 25733677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Series: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators.
    Zuidgeest MGP; Welsing PMJ; van Thiel GJMW; Ciaglia A; Alfonso-Cristancho R; Eckert L; Eijkemans MJC; Egger M;
    J Clin Epidemiol; 2017 Oct; 90():92-98. PubMed ID: 28694123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who is willing to participate in low-risk pragmatic clinical trials without consent?
    Dal-Ré R; Carcas AJ; Carné X
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1557-1563. PubMed ID: 28900674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Members of research ethics committees accepted a modification of the randomized consent design.
    Schellings R; Kessels AG; Ter Riet G; Kleijnen J; Leffers P; Knottnerus JA; Sturmans F
    J Clin Epidemiol; 2005 Jun; 58(6):589-94. PubMed ID: 15878472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principles and procedures for data and safety monitoring in pragmatic clinical trials.
    Simon GE; Shortreed SM; Rossom RC; Penfold RB; Sperl-Hillen JAM; O'Connor P
    Trials; 2019 Dec; 20(1):690. PubMed ID: 31815644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative Consent Models in Pragmatic Palliative Care Clinical Trials.
    Carpenter JG; Ulrich C; Hodgson N; Hanson LC; Ersek M
    J Pain Symptom Manage; 2021 Jul; 62(1):183-191. PubMed ID: 33129936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.